… its New Drug Application (NDA) for inhaled levodopa to the U.S. Food and Drug Administration (FDA). An NDA is … whole story of a drug: what happened in clinical trials, how the medication works in the body and how it's … expects to hear within 74 days whether their submission is complete and will be reviewed. A few months ago, the FDA …

… Image via Sunovion Pharmaceuticals Editor's Note (6/12/23):  In June 2023, Sunovion announced … know from our research and discussions with the Parkinson’s community that ‘off’ time can significantly disrupt daily … safety and efficacy. In the final step of clinical testing, more than 100 people with Parkinson’s evaluated the …

… New animated video, “Together, We Can Solve the Parkinson’s Puzzle,” aims to … to illustrate the role each individual within a family and community can play to help scientists piece together a …

… We propose studies in a pre-clinical model of PD to test the potential of Posiphen as a treatment of PD. Since Posiphen has been shown to be safe in three phase 1 safety trials in humans, … models have the gastrointestinal manifestations commonly seen in early PD, including constipation and slow …

… that the brains of people with Parkinson’s disease (PD) show a buildup of toxic proteins that is due to an impairment in the brain’s … waste clearance mechanisms. Disruptions in sleep, which are common in people with PD, have similarly been shown to … Jason A. Howitt, PhD …

… week, one of Central Virginia’s tastiest traditions returns to Charlottesville as students at the University of Virginia … Yonkman who believed in the power of pancakes to bring together students and the local community in support of a cause close to her heart. Since …